SWEDENCARE AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55 SEK | +0.64% |
|
0.00% | -9.78% |
| 04-25 | Swedencare AB Approves Dividend for the Year 2023, Payable on May 3, 2024 | CI |
| 04-25 | Transcript : Swedencare AB, Q1 2024 Earnings Call, Apr 25, 2024 |
| Sales 2024 * | 2.68B 245M 19.58B | Sales 2025 * | 3.01B 275M 22.01B | Capitalization | 8.73B 798M 63.87B |
|---|---|---|---|---|---|
| Net income 2024 * | 225M 20.57M 1.65B | Net income 2025 * | 356M 32.54M 2.6B | EV / Sales 2024 * | 3.64 x |
| Net Debt 2024 * | 1B 91.79M 7.35B | Net Debt 2025 * | 496M 45.37M 3.63B | EV / Sales 2025 * | 3.07 x |
| P/E ratio 2024 * |
38.8
x | P/E ratio 2025 * |
24.5
x | Employees | 560 |
| Yield 2024 * |
0.91% | Yield 2025 * |
1.45% | Free-Float | 35.04% |
More Fundamentals
* Assessed data
More news
Latest transcript on Swedencare AB
More press releases
| 1 day | +0.64% | ||
| Current month | -13.98% | ||
| 1 month | -18.47% | ||
| 3 months | -11.72% | ||
| 6 months | +27.58% | ||
| Current year | -9.78% |
1 week
53.95
59.75
1 month
53.9567.75
Current year
52.9869.12
1 year
27.1169.12
3 years
22.90159.00
5 years
11.60159.00
10 years
2.80159.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/13 | |
Jenny Graflind
DFI | Director of Finance/CFO | 48 | 31/12/16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 31/12/22 | |
| Director/Board Member | 57 | 31/12/15 | |
| Director/Board Member | 61 | 31/12/18 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 773 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 55 | +0.64% | 109,517 |
| 25/04/24 | 54.65 | -4.62% | 143,008 |
| 24/04/24 | 57.3 | -0.35% | 30,930 |
| 23/04/24 | 57.5 | -0.09% | 63,375 |
| 22/04/24 | 57.55 | +4.64% | 290,951 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 04:29 pm
More quotes
Swedencare publ AB is a Sweden-based company, which is mainly involved in the veterinary supplies industry. The Company operates as a provider of various products for animal health, distributed to veterinarians, pet stores and pharmacies. It operates through four subsidiaries, namely SDC Distribution for Scandinavian countries, Buccosante located in France, Informpet in the United Kingdom and SwedencareUSA in the United States. The Company's product portfolio includes ProDen product family, which consists of ProDen PlaqueOff Teeth and Gums, ProDen PlaqueOff Powder, ProDen PlaqueOff Powder Cat and ProDen PlaqueOff Dental Bites, among others. The products are available at veterinary clinics, pet retailers, pharmacies, health stores and dentist practices.
Sector
Pharmaceuticals
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
55
SEK
Average target price
68
SEK
Spread / Average Target
+23.64%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -9.78% | 796M | |
| -19.73% | 72.39B | |
| -11.01% | 6.54B | |
| +15.88% | 3.43B | |
| -2.92% | 3.12B | |
| -0.68% | 1.4B | |
| -17.27% | 1.34B | |
| -2.73% | 1.26B | |
| -14.67% | 1.12B | |
| -5.37% | 990M |
- Stock Market
- Equities
- SECARE Stock
